U.S. Approves More ‘Rapid’ COVID-19 Tests For Use On Frontlines

The U. S. Food and Drug Administration is approving more rapid molecular diagnostic tests that can be used in temporary screening locations, doctor’s office labs and nursing homes to detect the Coronavirus strain COVID-19 in less than a half hour.

Read the full post on Forbes - Healthcare